Global Active Pharmaceutical Ingredients Market Report 2019, Competitive Landscape, Trends and Opportunities
The Active Pharmaceutical Ingredients market has witnessed growth from USD XX million to USD XX million from 2014 to 2019. With the CAGR of X.X%, this market is estimated to reach USD XX million in 2026.
The report mainly studies the size, recent trends and development status of the Active Pharmaceutical Ingredients market, as well as investment opportunities, government policy, market dynamics (drivers, restraints, opportunities), supply chain and competitive landscape. Technological innovation and advancement will further optimize the performance of the product, making it more widely used in downstream applications. Moreover, Porter's Five Forces Analysis (potential entrants, suppliers, substitutes, buyers, industry competitors) provides crucial information for knowing the Active Pharmaceutical Ingredients market.
Major players in the global Active Pharmaceutical Ingredients market include:
AbbVie
Biocon
Sanofi
Lupin
Pfizer
North China Pharmaceutical Group
Sun Pharmaceutical Industries
DSM
Lonza Group
Johnson & Johnson
Boehringer Ingelheim
Hisun Pharmacy
Teva Pharmaceutical
Jiangsu Hengrui Medicine
Shandong Xinhua Pharmaceutical
Novartis International
Shandong Lukang Pharmaceutical
Huahai Pharmaceutical
Haerbin Pharmaceutical Group
Aurobindo Pharma
GlaxoSmithKline
Bayer
Bristol-Myers Squibb
Eli Lilly and Company
Merck & Co
On the basis of types, the Active Pharmaceutical Ingredients market is primarily split into:
Synthetic APIs
Biotech APIs
On the basis of applications, the market covers:
Oncology
Diabetes
Cardiovascular Disease
CNS and Neurological Disorders
Endocrinology
Other
Geographically, the report includes the research on production, consumption, revenue, market share and growth rate, and forecast (2014-2026) of the following regions:
Chapter 2 is about the market landscape and major players. It provides competitive situation and market concentration status along with the basic information of these players.
Chapter 3 provides a full-scale analysis of major players in Active Pharmaceutical Ingredients industry. The basic information, as well as the profiles, applications and specifications of products market performance along with Business Overview are offered.
Chapter 4 gives a worldwide view of Active Pharmaceutical Ingredients market. It includes production, market share revenue, price, and the growth rate by type.
Chapter 5 focuses on the application of Active Pharmaceutical Ingredients, by analyzing the consumption and its growth rate of each application.
Chapter 6 is about production, consumption, export, and import of Active Pharmaceutical Ingredients in each region.
Chapter 7 pays attention to the production, revenue, price and gross margin of Active Pharmaceutical Ingredients in markets of different regions. The analysis on production, revenue, price and gross margin of the global market is covered in this part.
Chapter 8 concentrates on manufacturing analysis, including key raw material analysis, cost structure analysis and process analysis, making up a comprehensive analysis of manufacturing cost.
Chapter 9 introduces the industrial chain of Active Pharmaceutical Ingredients. Industrial chain analysis, raw material sources and downstream buyers are analyzed in this chapter.
Chapter 10 provides clear insights into market dynamics.
Chapter 11 prospects the whole Active Pharmaceutical Ingredients market, including the global production and revenue forecast, regional forecast. It also foresees the Active Pharmaceutical Ingredients market by type and application.
Chapter 12 concludes the research findings and refines all the highlights of the study.
Chapter 13 introduces the research methodology and sources of research data for your understanding.
Years considered for this report:
The report mainly studies the size, recent trends and development status of the Active Pharmaceutical Ingredients market, as well as investment opportunities, government policy, market dynamics (drivers, restraints, opportunities), supply chain and competitive landscape. Technological innovation and advancement will further optimize the performance of the product, making it more widely used in downstream applications. Moreover, Porter's Five Forces Analysis (potential entrants, suppliers, substitutes, buyers, industry competitors) provides crucial information for knowing the Active Pharmaceutical Ingredients market.
Major players in the global Active Pharmaceutical Ingredients market include:
AbbVie
Biocon
Sanofi
Lupin
Pfizer
North China Pharmaceutical Group
Sun Pharmaceutical Industries
DSM
Lonza Group
Johnson & Johnson
Boehringer Ingelheim
Hisun Pharmacy
Teva Pharmaceutical
Jiangsu Hengrui Medicine
Shandong Xinhua Pharmaceutical
Novartis International
Shandong Lukang Pharmaceutical
Huahai Pharmaceutical
Haerbin Pharmaceutical Group
Aurobindo Pharma
GlaxoSmithKline
Bayer
Bristol-Myers Squibb
Eli Lilly and Company
Merck & Co
On the basis of types, the Active Pharmaceutical Ingredients market is primarily split into:
Synthetic APIs
Biotech APIs
On the basis of applications, the market covers:
Oncology
Diabetes
Cardiovascular Disease
CNS and Neurological Disorders
Endocrinology
Other
Geographically, the report includes the research on production, consumption, revenue, market share and growth rate, and forecast (2014-2026) of the following regions:
- United States
- Europe (Germany, UK, France, Italy, Spain, Russia, Poland)
- China
- Japan
- India
- Southeast Asia (Malaysia, Singapore, Philippines, Indonesia, Thailand, Vietnam)
- Central and South America (Brazil, Mexico, Colombia)
- Middle East and Africa (Saudi Arabia, United Arab Emirates, Turkey, Egypt, South Africa, Nigeria)
- Other Regions
Chapter 2 is about the market landscape and major players. It provides competitive situation and market concentration status along with the basic information of these players.
Chapter 3 provides a full-scale analysis of major players in Active Pharmaceutical Ingredients industry. The basic information, as well as the profiles, applications and specifications of products market performance along with Business Overview are offered.
Chapter 4 gives a worldwide view of Active Pharmaceutical Ingredients market. It includes production, market share revenue, price, and the growth rate by type.
Chapter 5 focuses on the application of Active Pharmaceutical Ingredients, by analyzing the consumption and its growth rate of each application.
Chapter 6 is about production, consumption, export, and import of Active Pharmaceutical Ingredients in each region.
Chapter 7 pays attention to the production, revenue, price and gross margin of Active Pharmaceutical Ingredients in markets of different regions. The analysis on production, revenue, price and gross margin of the global market is covered in this part.
Chapter 8 concentrates on manufacturing analysis, including key raw material analysis, cost structure analysis and process analysis, making up a comprehensive analysis of manufacturing cost.
Chapter 9 introduces the industrial chain of Active Pharmaceutical Ingredients. Industrial chain analysis, raw material sources and downstream buyers are analyzed in this chapter.
Chapter 10 provides clear insights into market dynamics.
Chapter 11 prospects the whole Active Pharmaceutical Ingredients market, including the global production and revenue forecast, regional forecast. It also foresees the Active Pharmaceutical Ingredients market by type and application.
Chapter 12 concludes the research findings and refines all the highlights of the study.
Chapter 13 introduces the research methodology and sources of research data for your understanding.
Years considered for this report:
- Historical Years: 2014-2018
- Base Year: 2019
- Estimated Year: 2019
- Forecast Period: 2019-2026
1 ACTIVE PHARMACEUTICAL INGREDIENTS MARKET OVERVIEW
1.1 Product Overview and Scope of Active Pharmaceutical Ingredients
1.2 Active Pharmaceutical Ingredients Segment by Type
1.2.1 Global Active Pharmaceutical Ingredients Production and CAGR (%) Comparison by Type (2014-2026)
1.2.2 The Market Profile of Synthetic APIs
1.2.3 The Market Profile of Biotech APIs
1.3 Global Active Pharmaceutical Ingredients Segment by Application
1.3.1 Active Pharmaceutical Ingredients Consumption (Sales) Comparison by Application (2014-2026)
1.3.2 The Market Profile of Oncology
1.3.3 The Market Profile of Diabetes
1.3.4 The Market Profile of Cardiovascular Disease
1.3.5 The Market Profile of CNS and Neurological Disorders
1.3.6 The Market Profile of Endocrinology
1.3.7 The Market Profile of Other
1.4 Global Active Pharmaceutical Ingredients Market by Region (2014-2026)
1.4.1 Global Active Pharmaceutical Ingredients Market Size (Value) and CAGR (%) Comparison by Region (2014-2026)
1.4.2 United States Active Pharmaceutical Ingredients Market Status and Prospect (2014-2026)
1.4.3 Europe Active Pharmaceutical Ingredients Market Status and Prospect (2014-2026)
1.4.3.1 Germany Active Pharmaceutical Ingredients Market Status and Prospect (2014-2026)
1.4.3.2 UK Active Pharmaceutical Ingredients Market Status and Prospect (2014-2026)
1.4.3.3 France Active Pharmaceutical Ingredients Market Status and Prospect (2014-2026)
1.4.3.4 Italy Active Pharmaceutical Ingredients Market Status and Prospect (2014-2026)
1.4.3.5 Spain Active Pharmaceutical Ingredients Market Status and Prospect (2014-2026)
1.4.3.6 Russia Active Pharmaceutical Ingredients Market Status and Prospect (2014-2026)
1.4.3.7 Poland Active Pharmaceutical Ingredients Market Status and Prospect (2014-2026)
1.4.4 China Active Pharmaceutical Ingredients Market Status and Prospect (2014-2026)
1.4.5 Japan Active Pharmaceutical Ingredients Market Status and Prospect (2014-2026)
1.4.6 India Active Pharmaceutical Ingredients Market Status and Prospect (2014-2026)
1.4.7 Southeast Asia Active Pharmaceutical Ingredients Market Status and Prospect (2014-2026)
1.4.7.1 Malaysia Active Pharmaceutical Ingredients Market Status and Prospect (2014-2026)
1.4.7.2 Singapore Active Pharmaceutical Ingredients Market Status and Prospect (2014-2026)
1.4.7.3 Philippines Active Pharmaceutical Ingredients Market Status and Prospect (2014-2026)
1.4.7.4 Indonesia Active Pharmaceutical Ingredients Market Status and Prospect (2014-2026)
1.4.7.5 Thailand Active Pharmaceutical Ingredients Market Status and Prospect (2014-2026)
1.4.7.6 Vietnam Active Pharmaceutical Ingredients Market Status and Prospect (2014-2026)
1.4.8 Central and South America Active Pharmaceutical Ingredients Market Status and Prospect (2014-2026)
1.4.8.1 Brazil Active Pharmaceutical Ingredients Market Status and Prospect (2014-2026)
1.4.8.2 Mexico Active Pharmaceutical Ingredients Market Status and Prospect (2014-2026)
1.4.8.3 Colombia Active Pharmaceutical Ingredients Market Status and Prospect (2014-2026)
1.4.9 Middle East and Africa Active Pharmaceutical Ingredients Market Status and Prospect (2014-2026)
1.4.9.1 Saudi Arabia Active Pharmaceutical Ingredients Market Status and Prospect (2014-2026)
1.4.9.2 United Arab Emirates Active Pharmaceutical Ingredients Market Status and Prospect (2014-2026)
1.4.9.3 Turkey Active Pharmaceutical Ingredients Market Status and Prospect (2014-2026)
1.4.9.4 Egypt Active Pharmaceutical Ingredients Market Status and Prospect (2014-2026)
1.4.9.5 South Africa Active Pharmaceutical Ingredients Market Status and Prospect (2014-2026)
1.4.9.6 Nigeria Active Pharmaceutical Ingredients Market Status and Prospect (2014-2026)
1.5 Global Market Size (Value) of Active Pharmaceutical Ingredients (2014-2026)
1.5.1 Global Active Pharmaceutical Ingredients Revenue Status and Outlook (2014-2026)
1.5.2 Global Active Pharmaceutical Ingredients Production Status and Outlook (2014-2026)
2 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET LANDSCAPE BY PLAYER
2.1 Global Active Pharmaceutical Ingredients Production and Share by Player (2014-2019)
2.2 Global Active Pharmaceutical Ingredients Revenue and Market Share by Player (2014-2019)
2.3 Global Active Pharmaceutical Ingredients Average Price by Player (2014-2019)
2.4 Active Pharmaceutical Ingredients Manufacturing Base Distribution, Sales Area and Product Type by Player
2.5 Active Pharmaceutical Ingredients Market Competitive Situation and Trends
2.5.1 Active Pharmaceutical Ingredients Market Concentration Rate
2.5.2 Active Pharmaceutical Ingredients Market Share of Top 3 and Top 6 Players
2.5.3 Mergers & Acquisitions, Expansion
3 PLAYERS PROFILES
3.1 AbbVie
3.1.1 AbbVie Basic Information, Manufacturing Base, Sales Area and Competitors
3.1.2 Active Pharmaceutical Ingredients Product Profiles, Application and Specification
3.1.3 AbbVie Active Pharmaceutical Ingredients Market Performance (2014-2019)
3.1.4 AbbVie Business Overview
3.2 Biocon
3.2.1 Biocon Basic Information, Manufacturing Base, Sales Area and Competitors
3.2.2 Active Pharmaceutical Ingredients Product Profiles, Application and Specification
3.2.3 Biocon Active Pharmaceutical Ingredients Market Performance (2014-2019)
3.2.4 Biocon Business Overview
3.3 Sanofi
3.3.1 Sanofi Basic Information, Manufacturing Base, Sales Area and Competitors
3.3.2 Active Pharmaceutical Ingredients Product Profiles, Application and Specification
3.3.3 Sanofi Active Pharmaceutical Ingredients Market Performance (2014-2019)
3.3.4 Sanofi Business Overview
3.4 Lupin
3.4.1 Lupin Basic Information, Manufacturing Base, Sales Area and Competitors
3.4.2 Active Pharmaceutical Ingredients Product Profiles, Application and Specification
3.4.3 Lupin Active Pharmaceutical Ingredients Market Performance (2014-2019)
3.4.4 Lupin Business Overview
3.5 Pfizer
3.5.1 Pfizer Basic Information, Manufacturing Base, Sales Area and Competitors
3.5.2 Active Pharmaceutical Ingredients Product Profiles, Application and Specification
3.5.3 Pfizer Active Pharmaceutical Ingredients Market Performance (2014-2019)
3.5.4 Pfizer Business Overview
3.6 North China Pharmaceutical Group
3.6.1 North China Pharmaceutical Group Basic Information, Manufacturing Base, Sales Area and Competitors
3.6.2 Active Pharmaceutical Ingredients Product Profiles, Application and Specification
3.6.3 North China Pharmaceutical Group Active Pharmaceutical Ingredients Market Performance (2014-2019)
3.6.4 North China Pharmaceutical Group Business Overview
3.7 Sun Pharmaceutical Industries
3.7.1 Sun Pharmaceutical Industries Basic Information, Manufacturing Base, Sales Area and Competitors
3.7.2 Active Pharmaceutical Ingredients Product Profiles, Application and Specification
3.7.3 Sun Pharmaceutical Industries Active Pharmaceutical Ingredients Market Performance (2014-2019)
3.7.4 Sun Pharmaceutical Industries Business Overview
3.8 DSM
3.8.1 DSM Basic Information, Manufacturing Base, Sales Area and Competitors
3.8.2 Active Pharmaceutical Ingredients Product Profiles, Application and Specification
3.8.3 DSM Active Pharmaceutical Ingredients Market Performance (2014-2019)
3.8.4 DSM Business Overview
3.9 Lonza Group
3.9.1 Lonza Group Basic Information, Manufacturing Base, Sales Area and Competitors
3.9.2 Active Pharmaceutical Ingredients Product Profiles, Application and Specification
3.9.3 Lonza Group Active Pharmaceutical Ingredients Market Performance (2014-2019)
3.9.4 Lonza Group Business Overview
3.10 Johnson & Johnson
3.10.1 Johnson & Johnson Basic Information, Manufacturing Base, Sales Area and Competitors
3.10.2 Active Pharmaceutical Ingredients Product Profiles, Application and Specification
3.10.3 Johnson & Johnson Active Pharmaceutical Ingredients Market Performance (2014-2019)
3.10.4 Johnson & Johnson Business Overview
3.11 Boehringer Ingelheim
3.11.1 Boehringer Ingelheim Basic Information, Manufacturing Base, Sales Area and Competitors
3.11.2 Active Pharmaceutical Ingredients Product Profiles, Application and Specification
3.11.3 Boehringer Ingelheim Active Pharmaceutical Ingredients Market Performance (2014-2019)
3.11.4 Boehringer Ingelheim Business Overview
3.12 Hisun Pharmacy
3.12.1 Hisun Pharmacy Basic Information, Manufacturing Base, Sales Area and Competitors
3.12.2 Active Pharmaceutical Ingredients Product Profiles, Application and Specification
3.12.3 Hisun Pharmacy Active Pharmaceutical Ingredients Market Performance (2014-2019)
3.12.4 Hisun Pharmacy Business Overview
3.13 Teva Pharmaceutical
3.13.1 Teva Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Competitors
3.13.2 Active Pharmaceutical Ingredients Product Profiles, Application and Specification
3.13.3 Teva Pharmaceutical Active Pharmaceutical Ingredients Market Performance (2014-2019)
3.13.4 Teva Pharmaceutical Business Overview
3.14 Jiangsu Hengrui Medicine
3.14.1 Jiangsu Hengrui Medicine Basic Information, Manufacturing Base, Sales Area and Competitors
3.14.2 Active Pharmaceutical Ingredients Product Profiles, Application and Specification
3.14.3 Jiangsu Hengrui Medicine Active Pharmaceutical Ingredients Market Performance (2014-2019)
3.14.4 Jiangsu Hengrui Medicine Business Overview
3.15 Shandong Xinhua Pharmaceutical
3.15.1 Shandong Xinhua Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Competitors
3.15.2 Active Pharmaceutical Ingredients Product Profiles, Application and Specification
3.15.3 Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredients Market Performance (2014-2019)
3.15.4 Shandong Xinhua Pharmaceutical Business Overview
3.16 Novartis International
3.16.1 Novartis International Basic Information, Manufacturing Base, Sales Area and Competitors
3.16.2 Active Pharmaceutical Ingredients Product Profiles, Application and Specification
3.16.3 Novartis International Active Pharmaceutical Ingredients Market Performance (2014-2019)
3.16.4 Novartis International Business Overview
3.17 Shandong Lukang Pharmaceutical
3.17.1 Shandong Lukang Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Competitors
3.17.2 Active Pharmaceutical Ingredients Product Profiles, Application and Specification
3.17.3 Shandong Lukang Pharmaceutical Active Pharmaceutical Ingredients Market Performance (2014-2019)
3.17.4 Shandong Lukang Pharmaceutical Business Overview
3.18 Huahai Pharmaceutical
3.18.1 Huahai Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Competitors
3.18.2 Active Pharmaceutical Ingredients Product Profiles, Application and Specification
3.18.3 Huahai Pharmaceutical Active Pharmaceutical Ingredients Market Performance (2014-2019)
3.18.4 Huahai Pharmaceutical Business Overview
3.19 Haerbin Pharmaceutical Group
3.19.1 Haerbin Pharmaceutical Group Basic Information, Manufacturing Base, Sales Area and Competitors
3.19.2 Active Pharmaceutical Ingredients Product Profiles, Application and Specification
3.19.3 Haerbin Pharmaceutical Group Active Pharmaceutical Ingredients Market Performance (2014-2019)
3.19.4 Haerbin Pharmaceutical Group Business Overview
3.20 Aurobindo Pharma
3.20.1 Aurobindo Pharma Basic Information, Manufacturing Base, Sales Area and Competitors
3.20.2 Active Pharmaceutical Ingredients Product Profiles, Application and Specification
3.20.3 Aurobindo Pharma Active Pharmaceutical Ingredients Market Performance (2014-2019)
3.20.4 Aurobindo Pharma Business Overview
3.21 GlaxoSmithKline
3.21.1 GlaxoSmithKline Basic Information, Manufacturing Base, Sales Area and Competitors
3.21.2 Active Pharmaceutical Ingredients Product Profiles, Application and Specification
3.21.3 GlaxoSmithKline Active Pharmaceutical Ingredients Market Performance (2014-2019)
3.21.4 GlaxoSmithKline Business Overview
3.22 Bayer
3.22.1 Bayer Basic Information, Manufacturing Base, Sales Area and Competitors
3.22.2 Active Pharmaceutical Ingredients Product Profiles, Application and Specification
3.22.3 Bayer Active Pharmaceutical Ingredients Market Performance (2014-2019)
3.22.4 Bayer Business Overview
3.23 Bristol-Myers Squibb
3.23.1 Bristol-Myers Squibb Basic Information, Manufacturing Base, Sales Area and Competitors
3.23.2 Active Pharmaceutical Ingredients Product Profiles, Application and Specification
3.23.3 Bristol-Myers Squibb Active Pharmaceutical Ingredients Market Performance (2014-2019)
3.23.4 Bristol-Myers Squibb Business Overview
3.24 Eli Lilly and Company
3.24.1 Eli Lilly and Company Basic Information, Manufacturing Base, Sales Area and Competitors
3.24.2 Active Pharmaceutical Ingredients Product Profiles, Application and Specification
3.24.3 Eli Lilly and Company Active Pharmaceutical Ingredients Market Performance (2014-2019)
3.24.4 Eli Lilly and Company Business Overview
3.25 Merck & Co
3.25.1 Merck & Co Basic Information, Manufacturing Base, Sales Area and Competitors
3.25.2 Active Pharmaceutical Ingredients Product Profiles, Application and Specification
3.25.3 Merck & Co Active Pharmaceutical Ingredients Market Performance (2014-2019)
3.25.4 Merck & Co Business Overview
4 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE
4.1 Global Active Pharmaceutical Ingredients Production and Market Share by Type (2014-2019)
4.2 Global Active Pharmaceutical Ingredients Revenue and Market Share by Type (2014-2019)
4.3 Global Active Pharmaceutical Ingredients Price by Type (2014-2019)
4.4 Global Active Pharmaceutical Ingredients Production Growth Rate by Type (2014-2019)
4.4.1 Global Active Pharmaceutical Ingredients Production Growth Rate of Synthetic APIs (2014-2019)
4.4.2 Global Active Pharmaceutical Ingredients Production Growth Rate of Biotech APIs (2014-2019)
5 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET ANALYSIS BY APPLICATION
5.1 Global Active Pharmaceutical Ingredients Consumption and Market Share by Application (2014-2019)
5.2 Global Active Pharmaceutical Ingredients Consumption Growth Rate by Application (2014-2019)
5.2.1 Global Active Pharmaceutical Ingredients Consumption Growth Rate of Oncology (2014-2019)
5.2.2 Global Active Pharmaceutical Ingredients Consumption Growth Rate of Diabetes (2014-2019)
5.2.3 Global Active Pharmaceutical Ingredients Consumption Growth Rate of Cardiovascular Disease (2014-2019)
5.2.4 Global Active Pharmaceutical Ingredients Consumption Growth Rate of CNS and Neurological Disorders (2014-2019)
5.2.5 Global Active Pharmaceutical Ingredients Consumption Growth Rate of Endocrinology (2014-2019)
5.2.6 Global Active Pharmaceutical Ingredients Consumption Growth Rate of Other (2014-2019)
6 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS PRODUCTION, CONSUMPTION, EXPORT, IMPORT BY REGION (2014-2019)
6.1 Global Active Pharmaceutical Ingredients Consumption by Region (2014-2019)
6.2 United States Active Pharmaceutical Ingredients Production, Consumption, Export, Import (2014-2019)
6.3 Europe Active Pharmaceutical Ingredients Production, Consumption, Export, Import (2014-2019)
6.4 China Active Pharmaceutical Ingredients Production, Consumption, Export, Import (2014-2019)
6.5 Japan Active Pharmaceutical Ingredients Production, Consumption, Export, Import (2014-2019)
6.6 India Active Pharmaceutical Ingredients Production, Consumption, Export, Import (2014-2019)
6.7 Southeast Asia Active Pharmaceutical Ingredients Production, Consumption, Export, Import (2014-2019)
6.8 Central and South America Active Pharmaceutical Ingredients Production, Consumption, Export, Import (2014-2019)
6.9 Middle East and Africa Active Pharmaceutical Ingredients Production, Consumption, Export, Import (2014-2019)
7 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS PRODUCTION, REVENUE (VALUE) BY REGION (2014-2019)
7.1 Global Active Pharmaceutical Ingredients Production and Market Share by Region (2014-2019)
7.2 Global Active Pharmaceutical Ingredients Revenue (Value) and Market Share by Region (2014-2019)
7.3 Global Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)
7.4 United States Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)
7.5 Europe Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)
7.6 China Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)
7.7 Japan Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)
7.8 India Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)
7.9 Southeast Asia Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)
7.10 Central and South America Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)
7.11 Middle East and Africa Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)
8 ACTIVE PHARMACEUTICAL INGREDIENTS MANUFACTURING ANALYSIS
8.1 Active Pharmaceutical Ingredients Key Raw Materials Analysis
8.1.1 Key Raw Materials Introduction
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Manufacturing Cost Analysis
8.2.1 Labor Cost Analysis
8.2.2 Manufacturing Cost Structure Analysis
8.3 Manufacturing Process Analysis of Active Pharmaceutical Ingredients
9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS
9.1 Active Pharmaceutical Ingredients Industrial Chain Analysis
9.2 Raw Materials Sources of Active Pharmaceutical Ingredients Major Players in 2018
9.3 Downstream Buyers
10 MARKET DYNAMICS
10.1 Drivers
10.2 Restraints
10.3 Opportunities
10.3.1 Advances in Innovation and Technology for Active Pharmaceutical Ingredients
10.3.2 Increased Demand in Emerging Markets
10.4 Challenges
10.4.1 The Performance of Alternative Product Type is Getting Better and Better
10.4.2 Price Variance Caused by Fluctuations in Raw Material Prices
10.5 Porter’s Five Forces Analysis
10.5.1 Threat of New Entrants
10.5.2 Threat of Substitutes
10.5.3 Bargaining Power of Suppliers
10.5.4 Bargaining Power of Buyers
10.5.5 Intensity of Competitive Rivalry
11 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FORECAST (2019-2026)
11.1 Global Active Pharmaceutical Ingredients Production, Revenue Forecast (2019-2026)
11.1.1 Global Active Pharmaceutical Ingredients Production and Growth Rate Forecast (2019-2026)
11.1.2 Global Active Pharmaceutical Ingredients Revenue and Growth Rate Forecast (2019-2026)
11.1.3 Global Active Pharmaceutical Ingredients Price and Trend Forecast (2019-2026)
11.2 Global Active Pharmaceutical Ingredients Production, Consumption, Export and Import Forecast by Region (2019-2026)
11.2.1 United States Active Pharmaceutical Ingredients Production, Consumption, Export and Import Forecast (2019-2026)
11.2.2 Europe Active Pharmaceutical Ingredients Production, Consumption, Export and Import Forecast (2019-2026)
11.2.3 China Active Pharmaceutical Ingredients Production, Consumption, Export and Import Forecast (2019-2026)
11.2.4 Japan Active Pharmaceutical Ingredients Production, Consumption, Export and Import Forecast (2019-2026)
11.2.5 India Active Pharmaceutical Ingredients Production, Consumption, Export and Import Forecast (2019-2026)
11.2.6 Southeast Asia Active Pharmaceutical Ingredients Production, Consumption, Export and Import Forecast (2019-2026)
11.2.7 Central and South America Active Pharmaceutical Ingredients Production, Consumption, Export and Import Forecast (2019-2026)
11.2.8 Middle East and Africa Active Pharmaceutical Ingredients Production, Consumption, Export and Import Forecast (2019-2026)
11.3 Global Active Pharmaceutical Ingredients Production, Revenue and Price Forecast by Type (2019-2026)
11.4 Global Active Pharmaceutical Ingredients Consumption Forecast by Application (2019-2026)
12 RESEARCH FINDINGS AND CONCLUSION
13 APPENDIX
13.1 Methodology
13.2 Research Data Source
1.1 Product Overview and Scope of Active Pharmaceutical Ingredients
1.2 Active Pharmaceutical Ingredients Segment by Type
1.2.1 Global Active Pharmaceutical Ingredients Production and CAGR (%) Comparison by Type (2014-2026)
1.2.2 The Market Profile of Synthetic APIs
1.2.3 The Market Profile of Biotech APIs
1.3 Global Active Pharmaceutical Ingredients Segment by Application
1.3.1 Active Pharmaceutical Ingredients Consumption (Sales) Comparison by Application (2014-2026)
1.3.2 The Market Profile of Oncology
1.3.3 The Market Profile of Diabetes
1.3.4 The Market Profile of Cardiovascular Disease
1.3.5 The Market Profile of CNS and Neurological Disorders
1.3.6 The Market Profile of Endocrinology
1.3.7 The Market Profile of Other
1.4 Global Active Pharmaceutical Ingredients Market by Region (2014-2026)
1.4.1 Global Active Pharmaceutical Ingredients Market Size (Value) and CAGR (%) Comparison by Region (2014-2026)
1.4.2 United States Active Pharmaceutical Ingredients Market Status and Prospect (2014-2026)
1.4.3 Europe Active Pharmaceutical Ingredients Market Status and Prospect (2014-2026)
1.4.3.1 Germany Active Pharmaceutical Ingredients Market Status and Prospect (2014-2026)
1.4.3.2 UK Active Pharmaceutical Ingredients Market Status and Prospect (2014-2026)
1.4.3.3 France Active Pharmaceutical Ingredients Market Status and Prospect (2014-2026)
1.4.3.4 Italy Active Pharmaceutical Ingredients Market Status and Prospect (2014-2026)
1.4.3.5 Spain Active Pharmaceutical Ingredients Market Status and Prospect (2014-2026)
1.4.3.6 Russia Active Pharmaceutical Ingredients Market Status and Prospect (2014-2026)
1.4.3.7 Poland Active Pharmaceutical Ingredients Market Status and Prospect (2014-2026)
1.4.4 China Active Pharmaceutical Ingredients Market Status and Prospect (2014-2026)
1.4.5 Japan Active Pharmaceutical Ingredients Market Status and Prospect (2014-2026)
1.4.6 India Active Pharmaceutical Ingredients Market Status and Prospect (2014-2026)
1.4.7 Southeast Asia Active Pharmaceutical Ingredients Market Status and Prospect (2014-2026)
1.4.7.1 Malaysia Active Pharmaceutical Ingredients Market Status and Prospect (2014-2026)
1.4.7.2 Singapore Active Pharmaceutical Ingredients Market Status and Prospect (2014-2026)
1.4.7.3 Philippines Active Pharmaceutical Ingredients Market Status and Prospect (2014-2026)
1.4.7.4 Indonesia Active Pharmaceutical Ingredients Market Status and Prospect (2014-2026)
1.4.7.5 Thailand Active Pharmaceutical Ingredients Market Status and Prospect (2014-2026)
1.4.7.6 Vietnam Active Pharmaceutical Ingredients Market Status and Prospect (2014-2026)
1.4.8 Central and South America Active Pharmaceutical Ingredients Market Status and Prospect (2014-2026)
1.4.8.1 Brazil Active Pharmaceutical Ingredients Market Status and Prospect (2014-2026)
1.4.8.2 Mexico Active Pharmaceutical Ingredients Market Status and Prospect (2014-2026)
1.4.8.3 Colombia Active Pharmaceutical Ingredients Market Status and Prospect (2014-2026)
1.4.9 Middle East and Africa Active Pharmaceutical Ingredients Market Status and Prospect (2014-2026)
1.4.9.1 Saudi Arabia Active Pharmaceutical Ingredients Market Status and Prospect (2014-2026)
1.4.9.2 United Arab Emirates Active Pharmaceutical Ingredients Market Status and Prospect (2014-2026)
1.4.9.3 Turkey Active Pharmaceutical Ingredients Market Status and Prospect (2014-2026)
1.4.9.4 Egypt Active Pharmaceutical Ingredients Market Status and Prospect (2014-2026)
1.4.9.5 South Africa Active Pharmaceutical Ingredients Market Status and Prospect (2014-2026)
1.4.9.6 Nigeria Active Pharmaceutical Ingredients Market Status and Prospect (2014-2026)
1.5 Global Market Size (Value) of Active Pharmaceutical Ingredients (2014-2026)
1.5.1 Global Active Pharmaceutical Ingredients Revenue Status and Outlook (2014-2026)
1.5.2 Global Active Pharmaceutical Ingredients Production Status and Outlook (2014-2026)
2 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET LANDSCAPE BY PLAYER
2.1 Global Active Pharmaceutical Ingredients Production and Share by Player (2014-2019)
2.2 Global Active Pharmaceutical Ingredients Revenue and Market Share by Player (2014-2019)
2.3 Global Active Pharmaceutical Ingredients Average Price by Player (2014-2019)
2.4 Active Pharmaceutical Ingredients Manufacturing Base Distribution, Sales Area and Product Type by Player
2.5 Active Pharmaceutical Ingredients Market Competitive Situation and Trends
2.5.1 Active Pharmaceutical Ingredients Market Concentration Rate
2.5.2 Active Pharmaceutical Ingredients Market Share of Top 3 and Top 6 Players
2.5.3 Mergers & Acquisitions, Expansion
3 PLAYERS PROFILES
3.1 AbbVie
3.1.1 AbbVie Basic Information, Manufacturing Base, Sales Area and Competitors
3.1.2 Active Pharmaceutical Ingredients Product Profiles, Application and Specification
3.1.3 AbbVie Active Pharmaceutical Ingredients Market Performance (2014-2019)
3.1.4 AbbVie Business Overview
3.2 Biocon
3.2.1 Biocon Basic Information, Manufacturing Base, Sales Area and Competitors
3.2.2 Active Pharmaceutical Ingredients Product Profiles, Application and Specification
3.2.3 Biocon Active Pharmaceutical Ingredients Market Performance (2014-2019)
3.2.4 Biocon Business Overview
3.3 Sanofi
3.3.1 Sanofi Basic Information, Manufacturing Base, Sales Area and Competitors
3.3.2 Active Pharmaceutical Ingredients Product Profiles, Application and Specification
3.3.3 Sanofi Active Pharmaceutical Ingredients Market Performance (2014-2019)
3.3.4 Sanofi Business Overview
3.4 Lupin
3.4.1 Lupin Basic Information, Manufacturing Base, Sales Area and Competitors
3.4.2 Active Pharmaceutical Ingredients Product Profiles, Application and Specification
3.4.3 Lupin Active Pharmaceutical Ingredients Market Performance (2014-2019)
3.4.4 Lupin Business Overview
3.5 Pfizer
3.5.1 Pfizer Basic Information, Manufacturing Base, Sales Area and Competitors
3.5.2 Active Pharmaceutical Ingredients Product Profiles, Application and Specification
3.5.3 Pfizer Active Pharmaceutical Ingredients Market Performance (2014-2019)
3.5.4 Pfizer Business Overview
3.6 North China Pharmaceutical Group
3.6.1 North China Pharmaceutical Group Basic Information, Manufacturing Base, Sales Area and Competitors
3.6.2 Active Pharmaceutical Ingredients Product Profiles, Application and Specification
3.6.3 North China Pharmaceutical Group Active Pharmaceutical Ingredients Market Performance (2014-2019)
3.6.4 North China Pharmaceutical Group Business Overview
3.7 Sun Pharmaceutical Industries
3.7.1 Sun Pharmaceutical Industries Basic Information, Manufacturing Base, Sales Area and Competitors
3.7.2 Active Pharmaceutical Ingredients Product Profiles, Application and Specification
3.7.3 Sun Pharmaceutical Industries Active Pharmaceutical Ingredients Market Performance (2014-2019)
3.7.4 Sun Pharmaceutical Industries Business Overview
3.8 DSM
3.8.1 DSM Basic Information, Manufacturing Base, Sales Area and Competitors
3.8.2 Active Pharmaceutical Ingredients Product Profiles, Application and Specification
3.8.3 DSM Active Pharmaceutical Ingredients Market Performance (2014-2019)
3.8.4 DSM Business Overview
3.9 Lonza Group
3.9.1 Lonza Group Basic Information, Manufacturing Base, Sales Area and Competitors
3.9.2 Active Pharmaceutical Ingredients Product Profiles, Application and Specification
3.9.3 Lonza Group Active Pharmaceutical Ingredients Market Performance (2014-2019)
3.9.4 Lonza Group Business Overview
3.10 Johnson & Johnson
3.10.1 Johnson & Johnson Basic Information, Manufacturing Base, Sales Area and Competitors
3.10.2 Active Pharmaceutical Ingredients Product Profiles, Application and Specification
3.10.3 Johnson & Johnson Active Pharmaceutical Ingredients Market Performance (2014-2019)
3.10.4 Johnson & Johnson Business Overview
3.11 Boehringer Ingelheim
3.11.1 Boehringer Ingelheim Basic Information, Manufacturing Base, Sales Area and Competitors
3.11.2 Active Pharmaceutical Ingredients Product Profiles, Application and Specification
3.11.3 Boehringer Ingelheim Active Pharmaceutical Ingredients Market Performance (2014-2019)
3.11.4 Boehringer Ingelheim Business Overview
3.12 Hisun Pharmacy
3.12.1 Hisun Pharmacy Basic Information, Manufacturing Base, Sales Area and Competitors
3.12.2 Active Pharmaceutical Ingredients Product Profiles, Application and Specification
3.12.3 Hisun Pharmacy Active Pharmaceutical Ingredients Market Performance (2014-2019)
3.12.4 Hisun Pharmacy Business Overview
3.13 Teva Pharmaceutical
3.13.1 Teva Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Competitors
3.13.2 Active Pharmaceutical Ingredients Product Profiles, Application and Specification
3.13.3 Teva Pharmaceutical Active Pharmaceutical Ingredients Market Performance (2014-2019)
3.13.4 Teva Pharmaceutical Business Overview
3.14 Jiangsu Hengrui Medicine
3.14.1 Jiangsu Hengrui Medicine Basic Information, Manufacturing Base, Sales Area and Competitors
3.14.2 Active Pharmaceutical Ingredients Product Profiles, Application and Specification
3.14.3 Jiangsu Hengrui Medicine Active Pharmaceutical Ingredients Market Performance (2014-2019)
3.14.4 Jiangsu Hengrui Medicine Business Overview
3.15 Shandong Xinhua Pharmaceutical
3.15.1 Shandong Xinhua Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Competitors
3.15.2 Active Pharmaceutical Ingredients Product Profiles, Application and Specification
3.15.3 Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredients Market Performance (2014-2019)
3.15.4 Shandong Xinhua Pharmaceutical Business Overview
3.16 Novartis International
3.16.1 Novartis International Basic Information, Manufacturing Base, Sales Area and Competitors
3.16.2 Active Pharmaceutical Ingredients Product Profiles, Application and Specification
3.16.3 Novartis International Active Pharmaceutical Ingredients Market Performance (2014-2019)
3.16.4 Novartis International Business Overview
3.17 Shandong Lukang Pharmaceutical
3.17.1 Shandong Lukang Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Competitors
3.17.2 Active Pharmaceutical Ingredients Product Profiles, Application and Specification
3.17.3 Shandong Lukang Pharmaceutical Active Pharmaceutical Ingredients Market Performance (2014-2019)
3.17.4 Shandong Lukang Pharmaceutical Business Overview
3.18 Huahai Pharmaceutical
3.18.1 Huahai Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Competitors
3.18.2 Active Pharmaceutical Ingredients Product Profiles, Application and Specification
3.18.3 Huahai Pharmaceutical Active Pharmaceutical Ingredients Market Performance (2014-2019)
3.18.4 Huahai Pharmaceutical Business Overview
3.19 Haerbin Pharmaceutical Group
3.19.1 Haerbin Pharmaceutical Group Basic Information, Manufacturing Base, Sales Area and Competitors
3.19.2 Active Pharmaceutical Ingredients Product Profiles, Application and Specification
3.19.3 Haerbin Pharmaceutical Group Active Pharmaceutical Ingredients Market Performance (2014-2019)
3.19.4 Haerbin Pharmaceutical Group Business Overview
3.20 Aurobindo Pharma
3.20.1 Aurobindo Pharma Basic Information, Manufacturing Base, Sales Area and Competitors
3.20.2 Active Pharmaceutical Ingredients Product Profiles, Application and Specification
3.20.3 Aurobindo Pharma Active Pharmaceutical Ingredients Market Performance (2014-2019)
3.20.4 Aurobindo Pharma Business Overview
3.21 GlaxoSmithKline
3.21.1 GlaxoSmithKline Basic Information, Manufacturing Base, Sales Area and Competitors
3.21.2 Active Pharmaceutical Ingredients Product Profiles, Application and Specification
3.21.3 GlaxoSmithKline Active Pharmaceutical Ingredients Market Performance (2014-2019)
3.21.4 GlaxoSmithKline Business Overview
3.22 Bayer
3.22.1 Bayer Basic Information, Manufacturing Base, Sales Area and Competitors
3.22.2 Active Pharmaceutical Ingredients Product Profiles, Application and Specification
3.22.3 Bayer Active Pharmaceutical Ingredients Market Performance (2014-2019)
3.22.4 Bayer Business Overview
3.23 Bristol-Myers Squibb
3.23.1 Bristol-Myers Squibb Basic Information, Manufacturing Base, Sales Area and Competitors
3.23.2 Active Pharmaceutical Ingredients Product Profiles, Application and Specification
3.23.3 Bristol-Myers Squibb Active Pharmaceutical Ingredients Market Performance (2014-2019)
3.23.4 Bristol-Myers Squibb Business Overview
3.24 Eli Lilly and Company
3.24.1 Eli Lilly and Company Basic Information, Manufacturing Base, Sales Area and Competitors
3.24.2 Active Pharmaceutical Ingredients Product Profiles, Application and Specification
3.24.3 Eli Lilly and Company Active Pharmaceutical Ingredients Market Performance (2014-2019)
3.24.4 Eli Lilly and Company Business Overview
3.25 Merck & Co
3.25.1 Merck & Co Basic Information, Manufacturing Base, Sales Area and Competitors
3.25.2 Active Pharmaceutical Ingredients Product Profiles, Application and Specification
3.25.3 Merck & Co Active Pharmaceutical Ingredients Market Performance (2014-2019)
3.25.4 Merck & Co Business Overview
4 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE
4.1 Global Active Pharmaceutical Ingredients Production and Market Share by Type (2014-2019)
4.2 Global Active Pharmaceutical Ingredients Revenue and Market Share by Type (2014-2019)
4.3 Global Active Pharmaceutical Ingredients Price by Type (2014-2019)
4.4 Global Active Pharmaceutical Ingredients Production Growth Rate by Type (2014-2019)
4.4.1 Global Active Pharmaceutical Ingredients Production Growth Rate of Synthetic APIs (2014-2019)
4.4.2 Global Active Pharmaceutical Ingredients Production Growth Rate of Biotech APIs (2014-2019)
5 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET ANALYSIS BY APPLICATION
5.1 Global Active Pharmaceutical Ingredients Consumption and Market Share by Application (2014-2019)
5.2 Global Active Pharmaceutical Ingredients Consumption Growth Rate by Application (2014-2019)
5.2.1 Global Active Pharmaceutical Ingredients Consumption Growth Rate of Oncology (2014-2019)
5.2.2 Global Active Pharmaceutical Ingredients Consumption Growth Rate of Diabetes (2014-2019)
5.2.3 Global Active Pharmaceutical Ingredients Consumption Growth Rate of Cardiovascular Disease (2014-2019)
5.2.4 Global Active Pharmaceutical Ingredients Consumption Growth Rate of CNS and Neurological Disorders (2014-2019)
5.2.5 Global Active Pharmaceutical Ingredients Consumption Growth Rate of Endocrinology (2014-2019)
5.2.6 Global Active Pharmaceutical Ingredients Consumption Growth Rate of Other (2014-2019)
6 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS PRODUCTION, CONSUMPTION, EXPORT, IMPORT BY REGION (2014-2019)
6.1 Global Active Pharmaceutical Ingredients Consumption by Region (2014-2019)
6.2 United States Active Pharmaceutical Ingredients Production, Consumption, Export, Import (2014-2019)
6.3 Europe Active Pharmaceutical Ingredients Production, Consumption, Export, Import (2014-2019)
6.4 China Active Pharmaceutical Ingredients Production, Consumption, Export, Import (2014-2019)
6.5 Japan Active Pharmaceutical Ingredients Production, Consumption, Export, Import (2014-2019)
6.6 India Active Pharmaceutical Ingredients Production, Consumption, Export, Import (2014-2019)
6.7 Southeast Asia Active Pharmaceutical Ingredients Production, Consumption, Export, Import (2014-2019)
6.8 Central and South America Active Pharmaceutical Ingredients Production, Consumption, Export, Import (2014-2019)
6.9 Middle East and Africa Active Pharmaceutical Ingredients Production, Consumption, Export, Import (2014-2019)
7 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS PRODUCTION, REVENUE (VALUE) BY REGION (2014-2019)
7.1 Global Active Pharmaceutical Ingredients Production and Market Share by Region (2014-2019)
7.2 Global Active Pharmaceutical Ingredients Revenue (Value) and Market Share by Region (2014-2019)
7.3 Global Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)
7.4 United States Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)
7.5 Europe Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)
7.6 China Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)
7.7 Japan Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)
7.8 India Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)
7.9 Southeast Asia Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)
7.10 Central and South America Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)
7.11 Middle East and Africa Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)
8 ACTIVE PHARMACEUTICAL INGREDIENTS MANUFACTURING ANALYSIS
8.1 Active Pharmaceutical Ingredients Key Raw Materials Analysis
8.1.1 Key Raw Materials Introduction
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Manufacturing Cost Analysis
8.2.1 Labor Cost Analysis
8.2.2 Manufacturing Cost Structure Analysis
8.3 Manufacturing Process Analysis of Active Pharmaceutical Ingredients
9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS
9.1 Active Pharmaceutical Ingredients Industrial Chain Analysis
9.2 Raw Materials Sources of Active Pharmaceutical Ingredients Major Players in 2018
9.3 Downstream Buyers
10 MARKET DYNAMICS
10.1 Drivers
10.2 Restraints
10.3 Opportunities
10.3.1 Advances in Innovation and Technology for Active Pharmaceutical Ingredients
10.3.2 Increased Demand in Emerging Markets
10.4 Challenges
10.4.1 The Performance of Alternative Product Type is Getting Better and Better
10.4.2 Price Variance Caused by Fluctuations in Raw Material Prices
10.5 Porter’s Five Forces Analysis
10.5.1 Threat of New Entrants
10.5.2 Threat of Substitutes
10.5.3 Bargaining Power of Suppliers
10.5.4 Bargaining Power of Buyers
10.5.5 Intensity of Competitive Rivalry
11 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FORECAST (2019-2026)
11.1 Global Active Pharmaceutical Ingredients Production, Revenue Forecast (2019-2026)
11.1.1 Global Active Pharmaceutical Ingredients Production and Growth Rate Forecast (2019-2026)
11.1.2 Global Active Pharmaceutical Ingredients Revenue and Growth Rate Forecast (2019-2026)
11.1.3 Global Active Pharmaceutical Ingredients Price and Trend Forecast (2019-2026)
11.2 Global Active Pharmaceutical Ingredients Production, Consumption, Export and Import Forecast by Region (2019-2026)
11.2.1 United States Active Pharmaceutical Ingredients Production, Consumption, Export and Import Forecast (2019-2026)
11.2.2 Europe Active Pharmaceutical Ingredients Production, Consumption, Export and Import Forecast (2019-2026)
11.2.3 China Active Pharmaceutical Ingredients Production, Consumption, Export and Import Forecast (2019-2026)
11.2.4 Japan Active Pharmaceutical Ingredients Production, Consumption, Export and Import Forecast (2019-2026)
11.2.5 India Active Pharmaceutical Ingredients Production, Consumption, Export and Import Forecast (2019-2026)
11.2.6 Southeast Asia Active Pharmaceutical Ingredients Production, Consumption, Export and Import Forecast (2019-2026)
11.2.7 Central and South America Active Pharmaceutical Ingredients Production, Consumption, Export and Import Forecast (2019-2026)
11.2.8 Middle East and Africa Active Pharmaceutical Ingredients Production, Consumption, Export and Import Forecast (2019-2026)
11.3 Global Active Pharmaceutical Ingredients Production, Revenue and Price Forecast by Type (2019-2026)
11.4 Global Active Pharmaceutical Ingredients Consumption Forecast by Application (2019-2026)
12 RESEARCH FINDINGS AND CONCLUSION
13 APPENDIX
13.1 Methodology
13.2 Research Data Source
LIST OF TABLES AND FIGURES
Figure Active Pharmaceutical Ingredients Product Picture
Table Global Active Pharmaceutical Ingredients Production and CAGR (%) Comparison by Type
Table Profile of Synthetic APIs
Table Profile of Biotech APIs
Table Active Pharmaceutical Ingredients Consumption (Sales) Comparison by Application (2014-2026)
Table Profile of Oncology
Table Profile of Diabetes
Table Profile of Cardiovascular Disease
Table Profile of CNS and Neurological Disorders
Table Profile of Endocrinology
Table Profile of Other
Figure Global Active Pharmaceutical Ingredients Market Size (Value) and CAGR (%) (2014-2026)
Figure United States Active Pharmaceutical Ingredients Revenue and Growth Rate (2014-2026)
Figure Europe Active Pharmaceutical Ingredients Revenue and Growth Rate (2014-2026)
Figure Germany Active Pharmaceutical Ingredients Revenue and Growth Rate (2014-2026)
Figure UK Active Pharmaceutical Ingredients Revenue and Growth Rate (2014-2026)
Figure France Active Pharmaceutical Ingredients Revenue and Growth Rate (2014-2026)
Figure Italy Active Pharmaceutical Ingredients Revenue and Growth Rate (2014-2026)
Figure Spain Active Pharmaceutical Ingredients Revenue and Growth Rate (2014-2026)
Figure Russia Active Pharmaceutical Ingredients Revenue and Growth Rate (2014-2026)
Figure Poland Active Pharmaceutical Ingredients Revenue and Growth Rate (2014-2026)
Figure China Active Pharmaceutical Ingredients Revenue and Growth Rate (2014-2026)
Figure Japan Active Pharmaceutical Ingredients Revenue and Growth Rate (2014-2026)
Figure India Active Pharmaceutical Ingredients Revenue and Growth Rate (2014-2026)
Figure Southeast Asia Active Pharmaceutical Ingredients Revenue and Growth Rate (2014-2026)
Figure Malaysia Active Pharmaceutical Ingredients Revenue and Growth Rate (2014-2026)
Figure Singapore Active Pharmaceutical Ingredients Revenue and Growth Rate (2014-2026)
Figure Philippines Active Pharmaceutical Ingredients Revenue and Growth Rate (2014-2026)
Figure Indonesia Active Pharmaceutical Ingredients Revenue and Growth Rate (2014-2026)
Figure Thailand Active Pharmaceutical Ingredients Revenue and Growth Rate (2014-2026)
Figure Vietnam Active Pharmaceutical Ingredients Revenue and Growth Rate (2014-2026)
Figure Central and South America Active Pharmaceutical Ingredients Revenue and Growth Rate (2014-2026)
Figure Brazil Active Pharmaceutical Ingredients Revenue and Growth Rate (2014-2026)
Figure Mexico Active Pharmaceutical Ingredients Revenue and Growth Rate (2014-2026)
Figure Colombia Active Pharmaceutical Ingredients Revenue and Growth Rate (2014-2026)
Figure Middle East and Africa Active Pharmaceutical Ingredients Revenue and Growth Rate (2014-2026)
Figure Saudi Arabia Active Pharmaceutical Ingredients Revenue and Growth Rate (2014-2026)
Figure United Arab Emirates Active Pharmaceutical Ingredients Revenue and Growth Rate (2014-2026)
Figure Turkey Active Pharmaceutical Ingredients Revenue and Growth Rate (2014-2026)
Figure Egypt Active Pharmaceutical Ingredients Revenue and Growth Rate (2014-2026)
Figure South Africa Active Pharmaceutical Ingredients Revenue and Growth Rate (2014-2026)
Figure Nigeria Active Pharmaceutical Ingredients Revenue and Growth Rate (2014-2026)
Figure Global Active Pharmaceutical Ingredients Production Status and Outlook (2014-2026)
Table Global Active Pharmaceutical Ingredients Production by Player (2014-2019)
Table Global Active Pharmaceutical Ingredients Production Share by Player (2014-2019)
Figure Global Active Pharmaceutical Ingredients Production Share by Player in 2018
Table Active Pharmaceutical Ingredients Revenue by Player (2014-2019)
Table Active Pharmaceutical Ingredients Revenue Market Share by Player (2014-2019)
Table Active Pharmaceutical Ingredients Price by Player (2014-2019)
Table Active Pharmaceutical Ingredients Manufacturing Base Distribution and Sales Area by Player
Table Active Pharmaceutical Ingredients Product Type by Player
Table Mergers & Acquisitions, Expansion Plans
Table AbbVie Profile
Table AbbVie Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)
Table Biocon Profile
Table Biocon Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)
Table Sanofi Profile
Table Sanofi Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)
Table Lupin Profile
Table Lupin Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)
Table Pfizer Profile
Table Pfizer Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)
Table North China Pharmaceutical Group Profile
Table North China Pharmaceutical Group Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)
Table Sun Pharmaceutical Industries Profile
Table Sun Pharmaceutical Industries Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)
Table DSM Profile
Table DSM Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)
Table Lonza Group Profile
Table Lonza Group Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)
Table Johnson & Johnson Profile
Table Johnson & Johnson Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)
Table Boehringer Ingelheim Profile
Table Boehringer Ingelheim Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)
Table Hisun Pharmacy Profile
Table Hisun Pharmacy Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)
Table Teva Pharmaceutical Profile
Table Teva Pharmaceutical Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)
Table Jiangsu Hengrui Medicine Profile
Table Jiangsu Hengrui Medicine Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)
Table Shandong Xinhua Pharmaceutical Profile
Table Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)
Table Novartis International Profile
Table Novartis International Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)
Table Shandong Lukang Pharmaceutical Profile
Table Shandong Lukang Pharmaceutical Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)
Table Huahai Pharmaceutical Profile
Table Huahai Pharmaceutical Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)
Table Haerbin Pharmaceutical Group Profile
Table Haerbin Pharmaceutical Group Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)
Table Aurobindo Pharma Profile
Table Aurobindo Pharma Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)
Table GlaxoSmithKline Profile
Table GlaxoSmithKline Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)
Table Bayer Profile
Table Bayer Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)
Table Bristol-Myers Squibb Profile
Table Bristol-Myers Squibb Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)
Table Eli Lilly and Company Profile
Table Eli Lilly and Company Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)
Table Merck & Co Profile
Table Merck & Co Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)
Table Global Active Pharmaceutical Ingredients Production by Type (2014-2019)
Table Global Active Pharmaceutical Ingredients Production Market Share by Type (2014-2019)
Figure Global Active Pharmaceutical Ingredients Production Market Share by Type in 2018
Table Global Active Pharmaceutical Ingredients Revenue by Type (2014-2019)
Table Global Active Pharmaceutical Ingredients Revenue Market Share by Type (2014-2019)
Figure Global Active Pharmaceutical Ingredients Revenue Market Share by Type in 2018
Table Active Pharmaceutical Ingredients Price by Type (2014-2019)
Figure Global Active Pharmaceutical Ingredients Production Growth Rate of Synthetic APIs (2014-2019)
Figure Global Active Pharmaceutical Ingredients Production Growth Rate of Biotech APIs (2014-2019)
Table Global Active Pharmaceutical Ingredients Consumption by Application (2014-2019)
Table Global Active Pharmaceutical Ingredients Consumption Market Share by Application (2014-2019)
Table Global Active Pharmaceutical Ingredients Consumption of Oncology (2014-2019)
Table Global Active Pharmaceutical Ingredients Consumption of Diabetes (2014-2019)
Table Global Active Pharmaceutical Ingredients Consumption of Cardiovascular Disease (2014-2019)
Table Global Active Pharmaceutical Ingredients Consumption of CNS and Neurological Disorders (2014-2019)
Table Global Active Pharmaceutical Ingredients Consumption of Endocrinology (2014-2019)
Table Global Active Pharmaceutical Ingredients Consumption of Other (2014-2019)
Table Global Active Pharmaceutical Ingredients Consumption by Region (2014-2019)
Table Global Active Pharmaceutical Ingredients Consumption Market Share by Region (2014-2019)
Table United States Active Pharmaceutical Ingredients Production, Consumption, Export, Import (2014-2019)
Table Europe Active Pharmaceutical Ingredients Production, Consumption, Export, Import (2014-2019)
Table China Active Pharmaceutical Ingredients Production, Consumption, Export, Import (2014-2019)
Table Japan Active Pharmaceutical Ingredients Production, Consumption, Export, Import (2014-2019)
Table India Active Pharmaceutical Ingredients Production, Consumption, Export, Import (2014-2019)
Table Southeast Asia Active Pharmaceutical Ingredients Production, Consumption, Export, Import (2014-2019)
Table Central and South America Active Pharmaceutical Ingredients Production, Consumption, Export, Import (2014-2019)
Table Middle East and Africa Active Pharmaceutical Ingredients Production, Consumption, Export, Import (2014-2019)
Table Global Active Pharmaceutical Ingredients Production by Region (2014-2019)
Table Global Active Pharmaceutical Ingredients Production Market Share by Region (2014-2019)
Figure Global Active Pharmaceutical Ingredients Production Market Share by Region (2014-2019)
Figure Global Active Pharmaceutical Ingredients Production Market Share by Region in 2018
Table Global Active Pharmaceutical Ingredients Revenue by Region (2014-2019)
Table Global Active Pharmaceutical Ingredients Revenue Market Share by Region (2014-2019)
Figure Global Active Pharmaceutical Ingredients Revenue Market Share by Region (2014-2019)
Figure Global Active Pharmaceutical Ingredients Revenue Market Share by Region in 2018
Table Global Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)
Table United States Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)
Table Europe Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)
Table China Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)
Table Japan Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)
Table India Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)
Table Southeast Asia Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)
Table Central and South America Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)
Table Middle East and Africa Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)
Table Key Raw Materials Introduction of Active Pharmaceutical Ingredients
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Market Concentration Rate of Raw Materials
Figure Manufacturing Cost Structure Analysis
Figure Manufacturing Process Analysis of Active Pharmaceutical Ingredients
Figure Active Pharmaceutical Ingredients Industrial Chain Analysis
Table Raw Materials Sources of Active Pharmaceutical Ingredients Major Players in 2018
Table Downstream Buyers
Figure Global Active Pharmaceutical Ingredients Production and Growth Rate Forecast (2019-2026)
Figure Global Active Pharmaceutical Ingredients Revenue and Growth Rate Forecast (2019-2026)
Figure Global Active Pharmaceutical Ingredients Price and Trend Forecast (2019-2026)
Table United States Active Pharmaceutical Ingredients Production, Consumption, Export and Import Forecast (2019-2026)
Table Europe
Figure Active Pharmaceutical Ingredients Product Picture
Table Global Active Pharmaceutical Ingredients Production and CAGR (%) Comparison by Type
Table Profile of Synthetic APIs
Table Profile of Biotech APIs
Table Active Pharmaceutical Ingredients Consumption (Sales) Comparison by Application (2014-2026)
Table Profile of Oncology
Table Profile of Diabetes
Table Profile of Cardiovascular Disease
Table Profile of CNS and Neurological Disorders
Table Profile of Endocrinology
Table Profile of Other
Figure Global Active Pharmaceutical Ingredients Market Size (Value) and CAGR (%) (2014-2026)
Figure United States Active Pharmaceutical Ingredients Revenue and Growth Rate (2014-2026)
Figure Europe Active Pharmaceutical Ingredients Revenue and Growth Rate (2014-2026)
Figure Germany Active Pharmaceutical Ingredients Revenue and Growth Rate (2014-2026)
Figure UK Active Pharmaceutical Ingredients Revenue and Growth Rate (2014-2026)
Figure France Active Pharmaceutical Ingredients Revenue and Growth Rate (2014-2026)
Figure Italy Active Pharmaceutical Ingredients Revenue and Growth Rate (2014-2026)
Figure Spain Active Pharmaceutical Ingredients Revenue and Growth Rate (2014-2026)
Figure Russia Active Pharmaceutical Ingredients Revenue and Growth Rate (2014-2026)
Figure Poland Active Pharmaceutical Ingredients Revenue and Growth Rate (2014-2026)
Figure China Active Pharmaceutical Ingredients Revenue and Growth Rate (2014-2026)
Figure Japan Active Pharmaceutical Ingredients Revenue and Growth Rate (2014-2026)
Figure India Active Pharmaceutical Ingredients Revenue and Growth Rate (2014-2026)
Figure Southeast Asia Active Pharmaceutical Ingredients Revenue and Growth Rate (2014-2026)
Figure Malaysia Active Pharmaceutical Ingredients Revenue and Growth Rate (2014-2026)
Figure Singapore Active Pharmaceutical Ingredients Revenue and Growth Rate (2014-2026)
Figure Philippines Active Pharmaceutical Ingredients Revenue and Growth Rate (2014-2026)
Figure Indonesia Active Pharmaceutical Ingredients Revenue and Growth Rate (2014-2026)
Figure Thailand Active Pharmaceutical Ingredients Revenue and Growth Rate (2014-2026)
Figure Vietnam Active Pharmaceutical Ingredients Revenue and Growth Rate (2014-2026)
Figure Central and South America Active Pharmaceutical Ingredients Revenue and Growth Rate (2014-2026)
Figure Brazil Active Pharmaceutical Ingredients Revenue and Growth Rate (2014-2026)
Figure Mexico Active Pharmaceutical Ingredients Revenue and Growth Rate (2014-2026)
Figure Colombia Active Pharmaceutical Ingredients Revenue and Growth Rate (2014-2026)
Figure Middle East and Africa Active Pharmaceutical Ingredients Revenue and Growth Rate (2014-2026)
Figure Saudi Arabia Active Pharmaceutical Ingredients Revenue and Growth Rate (2014-2026)
Figure United Arab Emirates Active Pharmaceutical Ingredients Revenue and Growth Rate (2014-2026)
Figure Turkey Active Pharmaceutical Ingredients Revenue and Growth Rate (2014-2026)
Figure Egypt Active Pharmaceutical Ingredients Revenue and Growth Rate (2014-2026)
Figure South Africa Active Pharmaceutical Ingredients Revenue and Growth Rate (2014-2026)
Figure Nigeria Active Pharmaceutical Ingredients Revenue and Growth Rate (2014-2026)
Figure Global Active Pharmaceutical Ingredients Production Status and Outlook (2014-2026)
Table Global Active Pharmaceutical Ingredients Production by Player (2014-2019)
Table Global Active Pharmaceutical Ingredients Production Share by Player (2014-2019)
Figure Global Active Pharmaceutical Ingredients Production Share by Player in 2018
Table Active Pharmaceutical Ingredients Revenue by Player (2014-2019)
Table Active Pharmaceutical Ingredients Revenue Market Share by Player (2014-2019)
Table Active Pharmaceutical Ingredients Price by Player (2014-2019)
Table Active Pharmaceutical Ingredients Manufacturing Base Distribution and Sales Area by Player
Table Active Pharmaceutical Ingredients Product Type by Player
Table Mergers & Acquisitions, Expansion Plans
Table AbbVie Profile
Table AbbVie Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)
Table Biocon Profile
Table Biocon Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)
Table Sanofi Profile
Table Sanofi Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)
Table Lupin Profile
Table Lupin Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)
Table Pfizer Profile
Table Pfizer Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)
Table North China Pharmaceutical Group Profile
Table North China Pharmaceutical Group Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)
Table Sun Pharmaceutical Industries Profile
Table Sun Pharmaceutical Industries Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)
Table DSM Profile
Table DSM Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)
Table Lonza Group Profile
Table Lonza Group Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)
Table Johnson & Johnson Profile
Table Johnson & Johnson Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)
Table Boehringer Ingelheim Profile
Table Boehringer Ingelheim Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)
Table Hisun Pharmacy Profile
Table Hisun Pharmacy Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)
Table Teva Pharmaceutical Profile
Table Teva Pharmaceutical Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)
Table Jiangsu Hengrui Medicine Profile
Table Jiangsu Hengrui Medicine Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)
Table Shandong Xinhua Pharmaceutical Profile
Table Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)
Table Novartis International Profile
Table Novartis International Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)
Table Shandong Lukang Pharmaceutical Profile
Table Shandong Lukang Pharmaceutical Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)
Table Huahai Pharmaceutical Profile
Table Huahai Pharmaceutical Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)
Table Haerbin Pharmaceutical Group Profile
Table Haerbin Pharmaceutical Group Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)
Table Aurobindo Pharma Profile
Table Aurobindo Pharma Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)
Table GlaxoSmithKline Profile
Table GlaxoSmithKline Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)
Table Bayer Profile
Table Bayer Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)
Table Bristol-Myers Squibb Profile
Table Bristol-Myers Squibb Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)
Table Eli Lilly and Company Profile
Table Eli Lilly and Company Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)
Table Merck & Co Profile
Table Merck & Co Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)
Table Global Active Pharmaceutical Ingredients Production by Type (2014-2019)
Table Global Active Pharmaceutical Ingredients Production Market Share by Type (2014-2019)
Figure Global Active Pharmaceutical Ingredients Production Market Share by Type in 2018
Table Global Active Pharmaceutical Ingredients Revenue by Type (2014-2019)
Table Global Active Pharmaceutical Ingredients Revenue Market Share by Type (2014-2019)
Figure Global Active Pharmaceutical Ingredients Revenue Market Share by Type in 2018
Table Active Pharmaceutical Ingredients Price by Type (2014-2019)
Figure Global Active Pharmaceutical Ingredients Production Growth Rate of Synthetic APIs (2014-2019)
Figure Global Active Pharmaceutical Ingredients Production Growth Rate of Biotech APIs (2014-2019)
Table Global Active Pharmaceutical Ingredients Consumption by Application (2014-2019)
Table Global Active Pharmaceutical Ingredients Consumption Market Share by Application (2014-2019)
Table Global Active Pharmaceutical Ingredients Consumption of Oncology (2014-2019)
Table Global Active Pharmaceutical Ingredients Consumption of Diabetes (2014-2019)
Table Global Active Pharmaceutical Ingredients Consumption of Cardiovascular Disease (2014-2019)
Table Global Active Pharmaceutical Ingredients Consumption of CNS and Neurological Disorders (2014-2019)
Table Global Active Pharmaceutical Ingredients Consumption of Endocrinology (2014-2019)
Table Global Active Pharmaceutical Ingredients Consumption of Other (2014-2019)
Table Global Active Pharmaceutical Ingredients Consumption by Region (2014-2019)
Table Global Active Pharmaceutical Ingredients Consumption Market Share by Region (2014-2019)
Table United States Active Pharmaceutical Ingredients Production, Consumption, Export, Import (2014-2019)
Table Europe Active Pharmaceutical Ingredients Production, Consumption, Export, Import (2014-2019)
Table China Active Pharmaceutical Ingredients Production, Consumption, Export, Import (2014-2019)
Table Japan Active Pharmaceutical Ingredients Production, Consumption, Export, Import (2014-2019)
Table India Active Pharmaceutical Ingredients Production, Consumption, Export, Import (2014-2019)
Table Southeast Asia Active Pharmaceutical Ingredients Production, Consumption, Export, Import (2014-2019)
Table Central and South America Active Pharmaceutical Ingredients Production, Consumption, Export, Import (2014-2019)
Table Middle East and Africa Active Pharmaceutical Ingredients Production, Consumption, Export, Import (2014-2019)
Table Global Active Pharmaceutical Ingredients Production by Region (2014-2019)
Table Global Active Pharmaceutical Ingredients Production Market Share by Region (2014-2019)
Figure Global Active Pharmaceutical Ingredients Production Market Share by Region (2014-2019)
Figure Global Active Pharmaceutical Ingredients Production Market Share by Region in 2018
Table Global Active Pharmaceutical Ingredients Revenue by Region (2014-2019)
Table Global Active Pharmaceutical Ingredients Revenue Market Share by Region (2014-2019)
Figure Global Active Pharmaceutical Ingredients Revenue Market Share by Region (2014-2019)
Figure Global Active Pharmaceutical Ingredients Revenue Market Share by Region in 2018
Table Global Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)
Table United States Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)
Table Europe Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)
Table China Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)
Table Japan Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)
Table India Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)
Table Southeast Asia Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)
Table Central and South America Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)
Table Middle East and Africa Active Pharmaceutical Ingredients Production, Revenue, Price and Gross Margin (2014-2019)
Table Key Raw Materials Introduction of Active Pharmaceutical Ingredients
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Market Concentration Rate of Raw Materials
Figure Manufacturing Cost Structure Analysis
Figure Manufacturing Process Analysis of Active Pharmaceutical Ingredients
Figure Active Pharmaceutical Ingredients Industrial Chain Analysis
Table Raw Materials Sources of Active Pharmaceutical Ingredients Major Players in 2018
Table Downstream Buyers
Figure Global Active Pharmaceutical Ingredients Production and Growth Rate Forecast (2019-2026)
Figure Global Active Pharmaceutical Ingredients Revenue and Growth Rate Forecast (2019-2026)
Figure Global Active Pharmaceutical Ingredients Price and Trend Forecast (2019-2026)
Table United States Active Pharmaceutical Ingredients Production, Consumption, Export and Import Forecast (2019-2026)
Table Europe
